Paloma Partners’s Guardant Health GH Stock Holding History

Paloma Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-185	Closed	-$5.34K	–	1365
2024 Q2	$5.34K	Buy	+185	New	+$4.31K	﹤0.01%	1211
2022 Q3	–	Sell	-19,400	Closed	-$783K	–	1137
2022 Q2	$783K	Buy	+19,400	New	+$961K	0.03%	502
2021 Q3	–	Sell	-18,423	Closed	-$2.29M	–	1395
2021 Q2	$2.29M	Buy	+18,423	New	+$2.48M	0.04%	390
2021 Q1	–	Sell	-5,489	Closed	-$708K	–	2147
2020 Q4	$708K	Sell	5,489 -3,136	-36%	-$361K	0.02%	726
2020 Q3	$964K	Sell	8,625 -1,559	-15%	-$143K	0.02%	757
2020 Q2	$826K	Buy	10,184 +2,584	+34%	+$208K	0.01%	1001
2020 Q1	$529K	Buy	7,600 +2,349	+45%	+$180K	0.03%	475
2019 Q4	$409K	Buy	+5,251	New	+$378K	0.01%	1534

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Paloma Partners's GH Position: Q3 2024 in Review

Paloma Partners sold out of Guardant Health (GH) in Q3 2024, closing a stake of 185 shares — an estimated $5.34K sold.

Paloma Partners first reported a position in GH in Q4 2019 and held it in 8 quarters. The position peaked at $2.29M in Q2 2021. 271 funds tracked by Wall St. Rank hold GH as of Q3 2024.

Paloma Partners reported no remaining Guardant Health position as of Q3 2024 after selling out during the quarter.
Paloma Partners sold 185 Guardant Health shares in Q3 2024, an estimated $5.34K.
Paloma Partners first reported a position in Guardant Health in Q4 2019 and held it in 8 quarters.
Paloma Partners's Guardant Health position peaked at $2.29M in Q2 2021.
271 funds tracked by Wall St. Rank held Guardant Health as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.